Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A.M. Saner, Alan Herschtal, Brad H. Nelson, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 6, pp. 339-348
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Tejas Jammihal, Renée Maria Saliby, Chris Labaki, et al.
Nature Cancer (2025)
Open Access | Times Cited: 4
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.
Blood Advances (2020) Vol. 4, Iss. 20, pp. 5011-5024
Open Access | Times Cited: 122
Polysaccharides of mushroom Pleurotus spp.: New extraction techniques, biological activities and development of new technologies
Jhonatas Rodrigues Barbosa, Maurício Madson dos Santos Freitas, Luiza Helena da Silva Martins, et al.
Carbohydrate Polymers (2019) Vol. 229, pp. 115550-115550
Closed Access | Times Cited: 104
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Dale W. Garsed, Ahwan Pandey, Sián Fereday, et al.
Nature Genetics (2022) Vol. 54, Iss. 12, pp. 1853-1864
Open Access | Times Cited: 59
Inhibiting tumor oxygen metabolism and simultaneously generating oxygen by intelligent upconversion nanotherapeutics for enhanced photodynamic therapy
Dan Wang, Bin Xue, Tymish Y. Ohulchanskyy, et al.
Biomaterials (2020) Vol. 251, pp. 120088-120088
Closed Access | Times Cited: 63
Occurrence and possible roles of polysaccharides in fungi and their influence on the development of new technologies
Jhonatas Rodrigues Barbosa, Raul Nunes de Carvalho
Carbohydrate Polymers (2020) Vol. 246, pp. 116613-116613
Open Access | Times Cited: 54
Extraction, Structural Characterization, Biological Functions, and Application of Rice Bran Polysaccharides: A Review
Bingjie Chen, Yongjin Qiao, Xiao Wang, et al.
Foods (2023) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 21
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
Christopher R. McEvoy, Huiling Xu, Kortnye Smith, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 5, pp. 1940-1945
Open Access | Times Cited: 46
Clinical characteristics and risk factors for mortality in cancer patients with COVID-19
Junnan Liang, Guan-nan Jin, Tongtong Liu, et al.
Frontiers of Medicine (2021) Vol. 15, Iss. 2, pp. 264-274
Open Access | Times Cited: 36
Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
Chang‐Shen Lin, Yu‐Tzu Chang, Zhen-Yang Hong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3238-3238
Open Access | Times Cited: 26
Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma
David M. O’Malley, Amit M. Oza, Domenica Lorusso, et al.
Gynecologic Oncology (2022) Vol. 167, Iss. 3, pp. 404-413
Open Access | Times Cited: 26
Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma
YiJiang Song, Yanyang Xu, Xiaojun Zhu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 33
Extraction, purification, characteristics, bioactivities, prospects, and toxicity of Lilium spp. polysaccharides
Chaohai Li, Zemei Zhu, Lei Cheng, et al.
International Journal of Biological Macromolecules (2023) Vol. 259, pp. 128532-128532
Closed Access | Times Cited: 11
Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma
Flurina A.M. Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 16, pp. 3481-3498
Open Access | Times Cited: 4
Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients
Andrei P. Drabovich, Punit Saraon, Mikalai Drabovich, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 9, pp. 1807-1823
Open Access | Times Cited: 34
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study
Barbara A. Conley, Lou Staudt, Naoko Takebe, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 1, pp. 27-37
Open Access | Times Cited: 25
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score
Cong Feng, Yinbin Zhang, Fei Wu, et al.
The Breast (2023) Vol. 69, pp. 392-400
Open Access | Times Cited: 9
Bioactive polysaccharides from Momordica charantia as functional ingredients: a review of their extraction, bioactivities, structural-activity relationships, and application prospects
Jiamei Zheng, Mingyue Shang, Guona Dai, et al.
Critical Reviews in Food Science and Nutrition (2023), pp. 1-24
Closed Access | Times Cited: 8
A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases
Daniel A. Anaya, Prashant Dogra, Zhihui Wang, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 444-444
Open Access | Times Cited: 19
Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S. Meagher, Phineas T. Hamilton, Katy Milne, et al.
Gynecologic Oncology (2022) Vol. 168, pp. 23-31
Open Access | Times Cited: 14
“I am not a statistic” ovarian cancer survivors’ views of factors that influenced their long-term survival
Aliya Alimujiang, Lilah Khoja, Ashley Wiensch, et al.
Gynecologic Oncology (2019) Vol. 155, Iss. 3, pp. 461-467
Open Access | Times Cited: 21
An Adenovirus‐Mimicking Photoactive Nanomachine Preferentially Invades and Destroys Cancer Cells through Hijacking Cellular Glucose Metabolism
Yu Zhang, Shujun Feng, Getian Hu, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 13
Closed Access | Times Cited: 17
In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia
Hande Ongün Yilmaz, Halil Ibrahim Toy, Stephan Marquardt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9601-9601
Open Access | Times Cited: 13
A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy
Taiying Chen, Ngalei Tam, Yu Mao, et al.
Materials Today Bio (2022) Vol. 16, pp. 100338-100338
Open Access | Times Cited: 10
<p>Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients</p>
Anna Pawłowska, Dorota Suszczyk, Rafał Tarkowski, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 9691-9709
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top